FADI S BRAITEH M.D. NPI 1538268438

NPI Information

  • NPI: 1538268438
  • Provider Name: FADI S BRAITEH, M.D.
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 3730 S EASTERN AVE
    LAS VEGAS, NV
    ZIP 89169
  • Phone: (702) 952-3400

Map and Directions

Get Directions

NPI Details

Fadi S Braiteh, M.D. is a medical oncology internal medicine in Las Vegas, NV with 28 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Fadi S Braiteh, M.D. NPI is 1538268438. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

3730 S EASTERN AVE
LAS VEGAS, NV
ZIP 89169
Phone: (702) 952-3400
Fax: (702) 952-3461

The NPI 1538268438 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, lanreotide, 1 mg (HCPCS:J1930)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Injection, irinotecan, 20 mg (HCPCS:J9206)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Vitamin d-3 level (HCPCS:82306)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Urinalysis, manual test (HCPCS:81002)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Unclassified drugs (HCPCS:J3490)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Hemoglobin a1c level (HCPCS:83036)
  • Alpha-fetoprotein (afp) level, serum (HCPCS:82105)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Blood test, clotting time (HCPCS:85610)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Testosterone (hormone) level, total (HCPCS:84403)
  • Ct scan of chest without contrast (HCPCS:71250)

The enumeration date for this NPI number is 9/21/2006 and was last updated on 2/28/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal MedicineL9109TEXASNo
2207RX0202XInternal MedicineMedical Oncology13623NEVADAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1177195801MEDICAIDTEXAS
20410515OTHERMICHIGANBCBSM PIN
3P00754153OTHERMICHIGANRR MEDICARE

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.